Carcinogenesis

Papers
(The H4-Index of Carcinogenesis is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Editor-In-Chief’s Editorial 202369
miR-1304 targets KLK11 to regulate gastric cancer cell proliferation through the mTOR signaling pathway50
LINC02418 upregulates EPHA2 by competitively sponging miR-372-3p to promote 5-Fu/DDP chemoresistance in colorectal cancer38
Regulatory mechanisms of PFKFB2 in glycolysis and tumor metabolism: implications for cancer therapy35
Cancer-testis non-coding RNA LEF1-AS1 regulates the nuclear translocation of PDCD5 and suppresses its interaction with p53 signaling: a novel target for immunotherapy in esophageal squamous cell carci29
Identification of HCAR1 as a ferroptosis-related biomarker of gastric cancer based on a novel ferroptosis-related prognostic model and in vitro experiments29
O-GlcNAcylation of RAB10 promotes hepatocellular carcinoma progression29
Longitudinal single-cell RNA model aids prediction of EGFR-TKI resistance29
Correction to: Triple-negative breast cancer molecular subtypes and potential detection targets for biological therapy indications26
Redefining pancreatic cancer management with tumor-agnostic precision medicine26
The environmental carcinogen benzo[a]pyrene regulates epigenetic reprogramming and metabolic rewiring in a two-stage mouse skin carcinogenesis model25
Expression of Concern: The promoting effects of hsa_circ_0050102 in pancreatic cancer and the molecular mechanism by targeting miR-1182/NPSR123
miR-22 promotes immunosuppression via activating JAK/STAT3 signaling in cutaneous squamous cell carcinoma22
Prognostic value of circulating tumor DNA in different cancer types detected by ultra-low-pass whole-genome sequencing: a systematic review and patient-level survival data meta-analysis21
Editor-in-Chief’s Note—Thank you to Reviewers20
Intratumoral vitamin D signaling and lethal prostate cancer19
Association between new plasma inflammatory markers and risk of colorectal neoplasms in individuals over 50 years old19
miR-3154 promotes hepatocellular carcinoma progression via suppressing HNF4α19
LMO3 is a suppressor of the basal-like/squamous subtype and reduces disease aggressiveness of pancreatic cancer through glycerol 3-phosphate metabolism18
Solamargine enhanced gefitinib antitumor effect via regulating MALAT1/miR-141-3p/Sp1/IGFBP1 signaling pathway in non-small cell lung cancer18
Ehm2 transcript variant 1 inhibits breast cancer progression and increases E-cadherin stability18
0.15444302558899